https://www.selleckchem.com/pr....oducts/beta-lapachon
Hepatocellular carcinoma (HCC) is one of the most prevalent cancer worldwide. Early detection of HCC is crucial to improve prognosis and survival. Nearly 30 % of HCC patients present with normal serum alpha fetoprotein (AFP), which highlights the need for new biomarkers for HCC. Annexin A4 (ANXA4) is one of the annexin family with high expressions found in gastric, liver, lung, colorectal and ovarian cancers. to evaluate the clinical significance of ANXA4 in the early diagnosis of HCC. Thirty patients with hepatitis C virus (HCV)
Like
Comment
Share
